If hot flashes and night sweats are disrupting your life, you have more than one treatment option. Veozah (fezolinetant) is a non-hormonal prescription medication specifically approved for moderate-to-severe vasomotor symptoms of menopause. Hormone therapy (HRT) uses estrogen, with progesterone or another progestogen when needed, and can treat hot flashes as well as several other menopause-related symptoms.
The important difference isn't simply which treatment is "better." Veozah and HRT work in completely different ways, have different benefits and risks, and may fit different medical situations and personal preferences.
Veozah vs. HRT at a Glance
| Factor | Veozah | HRT |
|---|---|---|
| Type | Non-hormonal medication | Hormone therapy |
| Primary use | Moderate-to-severe hot flashes and night sweats | Hot flashes, night sweats, and other menopause-related symptoms depending on the type of therapy |
| How it works | Blocks neurokinin-3 (NK3) receptors involved in temperature regulation | Replaces estrogen lost during the menopause transition; progesterone or another progestogen may be added when needed |
| Hormonal? | No | Yes |
| Liver monitoring | Yes. Baseline testing, then monthly for the first 3 months and again at months 6 and 9 | Not routinely required solely because of HRT, although individual medical conditions may require monitoring |
What Is Veozah?
Veozah is the brand name for fezolinetant, a non-hormonal medication called a neurokinin-3 (NK3) receptor antagonist. It is FDA-approved to treat moderate-to-severe vasomotor symptoms caused by menopause.
Unlike HRT, Veozah does not replace estrogen. Instead, it targets NK3 receptors involved in the brain's temperature-regulation system, which can become more sensitive during the menopause transition.
Clinical trials found that fezolinetant significantly reduced the frequency and severity of moderate-to-severe vasomotor symptoms compared with placebo. Improvements were observed within the first week and were maintained during longer-term follow-up.
For a more detailed look at how Veozah works, its effectiveness, side effects, liver monitoring, drug interactions and other safety information, see the complete Veozah menopause treatment guide.
What Is HRT?
Hormone therapy uses estrogen to replace some of the hormone that declines during the menopause transition. Depending on whether you have a uterus and your individual circumstances, progesterone or another progestogen may also be prescribed to protect the uterine lining.
Systemic estrogen can be delivered through several forms, including pills, patches, gels and sprays. Local vaginal estrogen is a different type of treatment used primarily for genitourinary symptoms such as vaginal dryness and discomfort.
Systemic hormone therapy is considered the most effective treatment for menopause-related hot flashes and night sweats. It can also help with other symptoms and conditions, including vaginal symptoms and bone loss, depending on the type of therapy used.
If you are new to HRT, our HRT 101 guide explains the basics, including estrogen, progesterone, different delivery methods and common questions about hormone therapy.
Which Is More Effective for Hot Flashes?
Both Veozah and HRT can significantly reduce hot flashes and night sweats, but there is an important limitation when comparing their effectiveness.
The major Veozah trials compared fezolinetant with placebo, not directly with HRT. In SKYLIGHT 1, women taking fezolinetant had statistically significant reductions in vasomotor symptom frequency and severity at weeks 4 and 12 compared with placebo. Improvements were observed as early as week 1.
HRT has a longer-established evidence base for vasomotor symptoms and is generally considered the most effective treatment for hot flashes and night sweats when it is medically appropriate.
That means you should be cautious about online charts claiming that Veozah reduces hot flashes by a specific percentage while HRT reduces them by another percentage. Those numbers can come from different studies, populations and study designs. They should not be interpreted as a head-to-head comparison.
What Symptoms Does Each Treatment Address?
Veozah
Veozah is specifically approved for moderate-to-severe vasomotor symptoms caused by menopause. That means hot flashes and night sweats are its primary treatment target.
Some studies have also found improvements in sleep disturbance and quality-of-life measures as vasomotor symptoms improve. However, Veozah should not be considered a treatment for every symptom associated with menopause.
For example, Veozah is not a treatment for vaginal dryness, genitourinary syndrome of menopause, or bone loss.
HRT
Systemic HRT can address a broader range of menopause-related symptoms because estrogen acts throughout the body. Depending on the formulation and individual circumstances, HRT may help with hot flashes, night sweats, vaginal symptoms, sleep problems and other menopause-related symptoms. Systemic estrogen also helps protect against menopause-related bone loss.
This doesn't mean HRT is automatically appropriate for every symptom or every woman. Treatment depends on your symptoms, medical history, age, timing of treatment and individual risks.
Veozah vs. HRT: How the Safety Profiles Differ
Veozah and HRT have different safety considerations because they work differently.
Veozah and Liver Safety
Veozah carries an FDA boxed warning for rare but serious liver injury. Liver testing is required before starting treatment and during treatment.
Under the current prescribing information, liver blood tests should be performed before starting Veozah, then monthly for the first 3 months and again at months 6 and 9. Additional testing may be needed if symptoms suggest liver injury.
Veozah should not be started in people with certain liver test abnormalities, and it is contraindicated in people with known cirrhosis. It is also contraindicated with severe renal impairment or end-stage renal disease and with concomitant use of CYP1A2 inhibitors.
HRT and Individual Risk Factors
HRT also has risks that need to be considered individually. Systemic hormone therapy is generally not recommended for women with certain medical histories, including some hormone-sensitive cancers, stroke, heart attack, blood clots or liver disease. The risks also vary depending on the type of hormone therapy, route of administration, age and when treatment is started.
For that reason, "hormonal" does not automatically mean unsafe, and "non-hormonal" does not automatically mean risk-free. The two treatments simply have different safety profiles.
What If You Can't or Don't Want to Take HRT?
This is one situation in which a non-hormonal treatment such as Veozah may be particularly relevant.
Some women have medical reasons to avoid systemic hormone therapy, while others may decide not to use hormones after discussing the potential benefits and risks with their healthcare professional. The Menopause Society lists fezolinetant among evidence-based nonhormonal treatments for vasomotor symptoms.
However, having a condition that makes HRT complicated does not automatically mean Veozah is the right alternative. Veozah has its own contraindications, interactions and liver-monitoring requirements.
Can You Take Veozah and HRT Together?
Veozah and HRT work through different mechanisms, but that does not mean everyone should combine them.
The pivotal Veozah trials were designed to evaluate fezolinetant as a treatment for vasomotor symptoms rather than establish a standard Veozah-plus-HRT treatment protocol. If someone is already using HRT and continues to have bothersome hot flashes or night sweats, the appropriate next step depends on the reason for the persistent symptoms, the current HRT regimen, and the person's medical history.
Do not change, stop or add prescription medications based solely on an online treatment comparison. Discuss the options with the healthcare professional managing your menopause treatment.
What About Switching From HRT to Veozah?
There is no universal switching schedule that applies to everyone.
If you are considering switching from HRT to Veozah, the decision should take into account why you are taking HRT in the first place. If HRT is helping with symptoms beyond hot flashes, switching to Veozah would not provide the same treatment coverage.
For example, someone using systemic HRT for hot flashes plus vaginal symptoms and protection against bone loss would need to discuss how those other treatment goals would be addressed if systemic HRT were stopped.
Cost: Veozah vs. HRT
Prescription costs can vary substantially depending on insurance coverage, the medication or formulation prescribed, pharmacy pricing and available savings programs.
For current Veozah pricing, insurance estimates and manufacturer savings information, see our Menopause Treatment Cost guide. We keep the detailed pricing there so this comparison article does not become outdated every time prescription prices change.
If you're trying to reduce your out-of-pocket medication costs, our guide to saving money on menopause treatment covers additional ways to look for lower prescription costs.
You can also check whether your menopause medications may qualify for an FSA or HSA through our FSA/HSA menopause medication guide.
Tracking Your Results
Whichever treatment you are considering, tracking your symptoms can make it easier to see whether your treatment is actually helping.
For Veozah, pay particular attention to the frequency, severity and timing of hot flashes and night sweats. Clinical trials evaluate these measures, and they can also give you useful information when discussing treatment with your healthcare professional.
The MenoHello Hot Flash Diary gives you a simple way to track these symptoms over time.
If you're tracking several menopause symptoms rather than hot flashes alone, the MenoHello Symptom Tracking toolkit can help you keep a broader record.
Questions to Ask Before Choosing Between Veozah and HRT
- Are hot flashes and night sweats my primary symptoms, or am I trying to address several menopause-related symptoms?
- Can I safely use systemic estrogen based on my medical history?
- Do I have a reason to avoid or reconsider HRT?
- Do I have liver or kidney conditions that could affect whether Veozah is appropriate?
- Do any of my medications interact with Veozah?
- Am I willing to have the required liver blood tests while taking Veozah?
- What symptoms am I trying to treat, and which of them would each treatment address?
- What will my prescription cost with my insurance or available savings programs?
- How will we know whether the treatment is working well enough?
Frequently Asked Questions About Veozah vs. HRT
Is Veozah as effective as HRT for hot flashes?
Veozah can significantly reduce moderate-to-severe hot flashes and night sweats. In clinical trials, fezolinetant reduced the frequency and severity of vasomotor symptoms compared with placebo, with improvements observed as early as the first week and significant differences demonstrated at weeks 4 and 12. However, the pivotal Veozah trials compared the medication with placebo, not directly with HRT, so the results should not be interpreted as a head-to-head comparison with hormone therapy.
Systemic estrogen therapy, with or without a progestin when needed, is considered the most effective treatment for hot flashes and night sweats by the American College of Obstetricians and Gynecologists.
Can Veozah replace HRT?
Veozah can be an alternative to HRT for treating moderate-to-severe hot flashes and night sweats, but it does not provide the same effects as hormone therapy. Veozah specifically targets vasomotor symptoms and does not replace estrogen in the body.
HRT may be used to treat hot flashes and night sweats as well as other menopause-related symptoms and to prevent menopause-related bone loss. Whether Veozah can meet your treatment goals depends on which symptoms and health concerns you are trying to address.
What is the difference between Veozah and HRT?
Veozah is a non-hormonal medication that blocks neurokinin-3 (NK3) receptors involved in the brain's temperature-regulation system. HRT uses hormones, primarily estrogen, to replace some of the estrogen lost during the menopause transition.
Veozah is specifically approved for moderate-to-severe vasomotor symptoms due to menopause. HRT can have a broader range of effects depending on the type of hormone therapy used, including treatment of hot flashes, night sweats, vaginal symptoms and prevention of menopause-related bone loss.
Does Veozah help with symptoms other than hot flashes?
Veozah is FDA-approved specifically for moderate-to-severe vasomotor symptoms associated with menopause, including hot flashes and night sweats. It is not approved as a general treatment for all menopause symptoms.
Some research has found improvements in sleep or quality-of-life measures when vasomotor symptoms improve, but this is different from directly treating conditions such as vaginal dryness, genitourinary symptoms or bone loss. Those symptoms may require separate treatment.
How quickly does Veozah work?
Some women may notice improvement during the first week. In the SKYLIGHT 1 clinical trial, reductions in vasomotor symptom frequency and severity were observed after one week, with statistically significant differences from placebo at weeks 4 and 12. Individual responses can vary.
Is Veozah safer than HRT?
There is no single answer to whether Veozah is "safer" because the two treatments have different benefits, risks and contraindications.
Veozah is non-hormonal, but it carries an FDA boxed warning for rare but serious liver injury and requires liver-function testing before and during treatment. HRT has different risks that depend on factors such as the type of hormone therapy, route of administration, age, timing of treatment and individual medical history.
A non-hormonal medication is not automatically risk-free, just as hormone therapy is not automatically inappropriate. The relevant question is which treatment's benefits, risks and monitoring requirements fit your individual situation.
Does Veozah require liver testing?
Yes. The current FDA prescribing information requires liver blood tests before starting Veozah, monthly for the first three months, and again at months 6 and 9. Additional testing may be needed if symptoms suggest liver injury.
The FDA added a boxed warning about rare but serious liver injury in December 2024 after reports of liver injury associated with Veozah.
Can you take Veozah and HRT together?
Veozah and HRT work through different mechanisms, but there is not a standard combination-treatment protocol established by the pivotal Veozah trials. If someone continues to have bothersome hot flashes while using HRT, the appropriate approach depends on the reason for the persistent symptoms, the current HRT regimen and the person's medical history.
Do not start, stop or combine prescription treatments without discussing the plan with the healthcare professional managing your menopause care.
Can I switch from HRT to Veozah?
A switch from HRT to Veozah may be an option for some people, but there is no universal switching schedule that applies to everyone.
An important consideration is what your HRT is treating. If you use HRT for hot flashes as well as vaginal symptoms, sleep-related symptoms or prevention of menopause-related bone loss, Veozah would not provide the same treatment effects. Your healthcare professional can help determine whether those treatment goals would need to be addressed separately.
Who should not take Veozah?
According to the current FDA prescribing information, Veozah is contraindicated in people with cirrhosis, severe renal impairment or end-stage renal disease, and in people taking CYP1A2 inhibitors. The prescribing information also contains restrictions related to liver function and other safety considerations.
Having a condition that makes HRT inappropriate does not automatically mean Veozah is appropriate. Your medications, liver and kidney function and overall medical history should be reviewed before treatment.
How do I decide between Veozah and HRT?
Start with the symptoms and treatment goals you want to address. If moderate-to-severe hot flashes and night sweats are the primary concern, both Veozah and HRT are treatment options when medically appropriate. HRT may also address other menopause-related symptoms and protect against menopause-related bone loss, while Veozah specifically targets vasomotor symptoms.
Other factors include your medical history, whether you can or want to use hormone therapy, Veozah's liver-monitoring requirements, medication interactions, cost and your preferences. There is no single treatment that is appropriate for everyone.
This article is for informational and educational purposes only and does not constitute medical advice. The information provided should not be used as a substitute for professional medical consultation, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding hormone therapy, bone health, osteoporosis prevention, or any medical condition.
Symptom Relief
Managing menopause symptoms can feel overwhelming, especially when effective solutions seem hard to find. From unexpected skin changes to frustrating hot flashes, these shifts can impact daily life and overall well-being. Explore our Symptom Relief page to discover products that other women have found helpful in managing their symptoms of perimenopause and menopause.
If you’ve found a product that has made a difference for you, let us know through our contact form—we’d love to share it with others!
Explore More
Want to dive deeper into menopause and its symptoms? Visit our Resources page, where you’ll find a collection of studies, articles, and books from trusted experts. Whether you're looking for the latest research or practical insights, these resources can help you better understand your body and make informed decisions about your menopause journey.
Related Reading:
Support for MenoHello
If you’ve found this helpful, your support helps keep MenoHello free, independent, and focused on providing clear, trusted menopause education for women in midlife.